Chemotherapy Induced Neutropenia Completed Phase 2 / 3 Trials for Pegfilgrastim (DB00019)

Also known as: Neutropenia post-chemotherapy / Chemotherapy-Induced Neutropenia / Chemotherapy Associated Neutropenia / Chemotherapy-induced neutropenia (disorder) / Neutropenia, unspecified / Neutropenia / Neutropenia (disorder) [Ambiguous] / Neutropenic disorder (disorder) / (Agranulocytosis) or (Kostmann's syndrome) or (neutropenia) / Neutropenias

IndicationStatusPhase
DBCOND0051348 (Chemotherapy Induced Neutropenia)Completed2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00837265Balugrastim (Neugranin) in Breast Cancer Participants Receiving Doxorubicin/DocetaxelSupportive Care
NCT01328938GCPGC in Chemotherapy-induced NeutropeniaPrevention